Cell therapies for autism spectrum disorder: a systematic review of clinical applications

Abstract Purpose Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects patients’ ability to communicate, engage with others, and behave in certain ways. Despite the existence of several therapy possibilities, an effective treatment for ASD has not yet been identified. Cell th...

Full description

Bibliographic Details
Main Authors: Ayberk Akat, Erdal Karaöz
Format: Article
Language:English
Published: SpringerOpen 2023-12-01
Series:Middle East Current Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s43045-023-00363-9
_version_ 1797416325219352576
author Ayberk Akat
Erdal Karaöz
author_facet Ayberk Akat
Erdal Karaöz
author_sort Ayberk Akat
collection DOAJ
description Abstract Purpose Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects patients’ ability to communicate, engage with others, and behave in certain ways. Despite the existence of several therapy possibilities, an effective treatment for ASD has not yet been identified. Cell therapies have been becoming increasingly recognized in recent years as a potential therapeutic approach for the management of ASD. Different types of cellular products are transplanted using different delivery methods as part of cell therapy, which has the ability to regulate the immune system, demonstrate paracrine, neuro-regenerative, anti-inflammatory, and anti-oxidative stress effects, as well as transfer healthy mitochondria. We have compared the results and findings of completed cell therapy clinical trials for the treatment of ASD in this systematic review. Methods A total of 547 studies were identified, in which 11 studies were found to be eligible to be included in this review as they were completed cell therapy clinical trials or clinical applications with quantitative results for the treatment of ASD patients. Results This systematic review provides an overview of clinical trials conducted with different types of cell therapy strategies for the treatment of ASD and their potential mechanisms of action. The limitations and future possibilities for this field of study, as well as the safety and efficacy of cell treatments in ASD, were reviewed. Conclusion Overall, the evidence suggests that various cell therapy methods may offer a novel and effective treatment option for individuals with ASD, although further research is needed to fully understand the optimal treatment strategy and therapeutic potential.
first_indexed 2024-03-09T06:01:42Z
format Article
id doaj.art-d378039d67224415aefb12529910c0f4
institution Directory Open Access Journal
issn 2090-5416
language English
last_indexed 2024-03-09T06:01:42Z
publishDate 2023-12-01
publisher SpringerOpen
record_format Article
series Middle East Current Psychiatry
spelling doaj.art-d378039d67224415aefb12529910c0f42023-12-03T12:08:47ZengSpringerOpenMiddle East Current Psychiatry2090-54162023-12-0130111710.1186/s43045-023-00363-9Cell therapies for autism spectrum disorder: a systematic review of clinical applicationsAyberk Akat0Erdal Karaöz1Life Park Hospital, Cellular and Biological Products Manufacturing CenterLiv Hospital Ulus, Regenerative Medicine and Stem Cell CenterAbstract Purpose Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects patients’ ability to communicate, engage with others, and behave in certain ways. Despite the existence of several therapy possibilities, an effective treatment for ASD has not yet been identified. Cell therapies have been becoming increasingly recognized in recent years as a potential therapeutic approach for the management of ASD. Different types of cellular products are transplanted using different delivery methods as part of cell therapy, which has the ability to regulate the immune system, demonstrate paracrine, neuro-regenerative, anti-inflammatory, and anti-oxidative stress effects, as well as transfer healthy mitochondria. We have compared the results and findings of completed cell therapy clinical trials for the treatment of ASD in this systematic review. Methods A total of 547 studies were identified, in which 11 studies were found to be eligible to be included in this review as they were completed cell therapy clinical trials or clinical applications with quantitative results for the treatment of ASD patients. Results This systematic review provides an overview of clinical trials conducted with different types of cell therapy strategies for the treatment of ASD and their potential mechanisms of action. The limitations and future possibilities for this field of study, as well as the safety and efficacy of cell treatments in ASD, were reviewed. Conclusion Overall, the evidence suggests that various cell therapy methods may offer a novel and effective treatment option for individuals with ASD, although further research is needed to fully understand the optimal treatment strategy and therapeutic potential.https://doi.org/10.1186/s43045-023-00363-9Autism spectrum disorderCell therapyClinical trialsStem cells
spellingShingle Ayberk Akat
Erdal Karaöz
Cell therapies for autism spectrum disorder: a systematic review of clinical applications
Middle East Current Psychiatry
Autism spectrum disorder
Cell therapy
Clinical trials
Stem cells
title Cell therapies for autism spectrum disorder: a systematic review of clinical applications
title_full Cell therapies for autism spectrum disorder: a systematic review of clinical applications
title_fullStr Cell therapies for autism spectrum disorder: a systematic review of clinical applications
title_full_unstemmed Cell therapies for autism spectrum disorder: a systematic review of clinical applications
title_short Cell therapies for autism spectrum disorder: a systematic review of clinical applications
title_sort cell therapies for autism spectrum disorder a systematic review of clinical applications
topic Autism spectrum disorder
Cell therapy
Clinical trials
Stem cells
url https://doi.org/10.1186/s43045-023-00363-9
work_keys_str_mv AT ayberkakat celltherapiesforautismspectrumdisorderasystematicreviewofclinicalapplications
AT erdalkaraoz celltherapiesforautismspectrumdisorderasystematicreviewofclinicalapplications